FP5Individual fellowship2000–2001
Synthesis and biological evaluation of new anticancer drugs consisting of two parts, a delivery vehicle and a powerful warhead.
FP5 — Improving Human Research Potential
- Duration
- 2000-01-15 → 2001-01-14
- EU contribution
- €57,336
- Participants
- 1
- Scheme
- RGI
Lines connect the coordinator with its partners.
Participants
- UNIVERSITY OF GLASGOW · GLASGOWCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union